The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...